Finepoint Capital’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,489,025
| Closed | -$21.1M | – | 27 |
|
|
2023
Q4 | $21.1M | Hold |
1,489,025
| – | – | 6.67% | 3 |
|
|
2023
Q3 | $18.1M | Buy |
1,489,025
+163,250
| +12% | +$1.99M | 9.02% | 2 |
|
|
2023
Q2 | $16.7M | Sell |
1,325,775
-134,400
| -9% | -$1.69M | 5.76% | 5 |
|
|
2023
Q1 | $16.2M | Buy |
1,460,175
+31,700
| +2% | +$352K | 6.19% | 9 |
|
|
2022
Q4 | $17.4M | Sell |
1,428,475
-259,925
| -15% | -$3.17M | 5.64% | 6 |
|
|
2022
Q3 | $17.6M | Sell |
1,688,400
-322,500
| -16% | -$3.37M | 5.8% | 9 |
|
|
2022
Q2 | $21.6M | Buy |
+2,010,900
| New | +$21.6M | 7.47% | 2 |
|